1. Home
  2. TYRA vs GOOD Comparison

TYRA vs GOOD Comparison

Compare TYRA & GOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$22.54

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Gladstone Commercial Corporation Real Estate Investment Trust

GOOD

Gladstone Commercial Corporation Real Estate Investment Trust

HOLD

Current Price

$10.89

Market Cap

533.4M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
TYRA
GOOD
Founded
2018
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
533.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TYRA
GOOD
Price
$22.54
$10.89
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$31.20
$11.00
AVG Volume (30 Days)
570.8K
511.4K
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
11.06%
EPS Growth
N/A
N/A
EPS
N/A
0.18
Revenue
N/A
$155,250,000.00
Revenue This Year
N/A
$8.62
Revenue Next Year
N/A
$6.07
P/E Ratio
N/A
$59.17
Revenue Growth
N/A
4.95
52 Week Low
$6.42
$10.47
52 Week High
$24.05
$17.01

Technical Indicators

Market Signals
Indicator
TYRA
GOOD
Relative Strength Index (RSI) 69.31 47.44
Support Level $21.66 $10.65
Resistance Level $24.05 $10.97
Average True Range (ATR) 1.31 0.19
MACD -0.05 0.03
Stochastic Oscillator 67.04 62.47

Price Performance

Historical Comparison
TYRA
GOOD

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About GOOD Gladstone Commercial Corporation Real Estate Investment Trust

Gladstone Commercial Corp is a real estate investment trust, which engages in investing and owning net leased industrial, commercial, and retail real property and making long-term industrial and commercial mortgage loans. Its portfolio consists of single-tenant commercial, industrial real properties, and medical properties nationwide. Its principal investment objectives are to generate income from rental properties.

Share on Social Networks: